Become a Member
  • Track your favourite stocks
  • Create & monitor portfolios
  • Daily portfolio value
Sign Up
Quickpicks
Add shares to your
quickpicks to
display them here!

Physiomics (PYC) Share Price

Price 0.415p on 04-07-2025 at 17:35:09
Change -0.01p -2.35%
Buy 0.43p
Sell 0.40p
Buy / Sell PYC Shares
Last Trade: Buy 275,000.00 at 0.424p
Day's Volume: 2,449,924
Last Close: 0.415p
Open: 0.425p
ISIN: GB00BDR6W943
Day's Range 0.415p - 0.425p
52wk Range: 0.39p - 1.325p
Market Capitalisation: £1m
VWAP: 0.416162p
Shares in Issue: 303m

Physiomics (PYC) Latest Trades

Buy/Sell Volume Trade Prc Trade Type Trade Time
Buy* 275,000 0.424p Ordinary
16:19:27 - 04-Jul-25
Buy* 500,000 0.424p Ordinary
15:57:52 - 04-Jul-25
Sell* 1,000,000 0.40p Ordinary
15:32:31 - 04-Jul-25
Buy* 33,798 0.432p Ordinary
12:54:36 - 04-Jul-25
Buy* 11,718 0.432p Ordinary
11:58:42 - 04-Jul-25
Sell* 11,718 0.4065p Ordinary
11:23:06 - 04-Jul-25
Buy* 250,000 0.431p Ordinary
10:25:43 - 04-Jul-25
Buy* 50,000 0.431p Ordinary
10:17:23 - 04-Jul-25
Buy* 11,574 0.432p Ordinary
09:36:27 - 04-Jul-25
Buy* 300,000 0.432p Ordinary
09:31:52 - 04-Jul-25
See more Physiomics trades

Physiomics (PYC) Share Price History

Time period:
to
Date Open High Low Close Volume
4th Jul 2025 (Fri) 0.425 0.425 0.415 0.415 2,449,924
3rd Jul 2025 (Thu) 0.445 0.445 0.415 0.425 7,091,249
2nd Jul 2025 (Wed) 0.475 0.475 0.445 0.445 1,950,923
1st Jul 2025 (Tue) 0.475 0.475 0.475 0.475 3,318,097
30th Jun 2025 (Mon) 0.475 0.475 0.465 0.465 2,949,512
27th Jun 2025 (Fri) 0.475 0.475 0.475 0.475 1,620,304
26th Jun 2025 (Thu) 0.49 0.49 0.475 0.475 2,924,750
25th Jun 2025 (Wed) 0.49 0.49 0.49 0.49 669,625
24th Jun 2025 (Tue) 0.46 0.49 0.46 0.49 1,941,171
23rd Jun 2025 (Mon) 0.50 0.50 0.46 0.46 4,192,026
20th Jun 2025 (Fri) 0.50 0.50 0.50 0.50 3,359,039
19th Jun 2025 (Thu) 0.50 0.50 0.50 0.50 788,480
18th Jun 2025 (Wed) 0.50 0.50 0.50 0.50 1,824,772
17th Jun 2025 (Tue) 0.50 0.50 0.50 0.50 3,356,343
16th Jun 2025 (Mon) 0.495 0.515 0.49 0.50 9,128,082
13th Jun 2025 (Fri) 0.45 0.46 0.45 0.46 645,557
12th Jun 2025 (Thu) 0.455 0.455 0.44 0.45 2,512,882
11th Jun 2025 (Wed) 0.46 0.46 0.455 0.455 920,701
10th Jun 2025 (Tue) 0.475 0.475 0.425 0.46 13,222,838
9th Jun 2025 (Mon) 0.475 0.475 0.475 0.475 2,400,000
6th Jun 2025 (Fri) 0.47 0.475 0.46 0.475 3,199,207
See more Physiomics price history

Physiomics (PYC) Regulatory News

Date Source Headline
1st Jul 2025 7:00 am RNS Contract Award
16th Jun 2025 7:00 am RNS New Head of Biometrics and Two Contracts Awarded
29th May 2025 7:00 am RNS Physiomics Awarded Contract Extension
9th May 2025 7:00 am RNS Contract Award with New UK Client
7th May 2025 4:45 pm RNS AIM Rule 17 and Schedule 2(g) Update
17th Apr 2025 7:00 am RNS-R Physiomics Awarded New Contract
16th Apr 2025 7:00 am RNS-R Publication of Peer Reviewed Article
15th Apr 2025 7:00 am RNS-R Contract Award
17th Mar 2025 7:00 am RNS Contract Award with new client
13th Mar 2025 7:00 am RNS-R IMC Presentation on Company Website
See more Physiomics regulatory news

Physiomics (PYC) Share News

Physiomics deepens ties with existing client as inks new contract

1st Jul 2025 15:31

(Alliance News) - Physiomics PLC on Tuesday reported the signing of a new contract, as it looks to accelerate the development of a "promising" drug programme. Read More

AIM WINNERS & LOSERS: Physiomics wins first ever Biometrics deals

16th Jun 2025 10:17

(Alliance News) - The following stocks are the leading risers and fallers on AIM on Monday. Read More

Physiomics wins clinical development contract with new UK client

9th May 2025 13:06

(Alliance News) - Physiomics PLC on Friday said it has won a contract with a new client in the UK. Read More

Physiomics extends long-term collaboration with Numab via new contract

15th Apr 2025 18:23

(Alliance News) - Physiomics PLC on Tuesday said it has secured a new contract with long-standing client Numab Therapeutics AG, a Swiss clinical stage biotech company focused on the development of multi-specific antibodies in immunology and oncology. Read More

IN BRIEF: Physiomics secures GBP102,000 model development contract

17th Mar 2025 16:22

Physiomics PLC - Oxfordshire, England-based mathematical modelling company that supports oncology drug development - Secures contract worth GBP102,000 with a new UK-based biotech firm that is focused on developing antibody drug conjugates based therapies targeting difficult-to-treat cancers. Says the contract will see it develop a pharmacokinetic pharmacodynamic model to inform optimal dosing for the client's upcoming first-in-human trial. Expects the project to run from April until August this year. Chief Executive Peter Sargent says: "We are delighted to be awarded this contract. Not only is this contract with a brand new client, but is also in the area of ADCs; a hot new area of oncology treatments." Read More

See more Physiomics news
FTSE 100 Latest
Value8,822.91
Change-0.29

Login to your account

Forgot Password?

Not Registered